prometa software version 2 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
prometa software version 2
Prometa Software Version 2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prometa+software/prometa+software++version+2/pm29427770-57-5-13
Average 90 stars, based on 1 article reviews
Prometa Software Version 2, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prometa+software/prometa+software++version+2/pm29427770-57-5-13
Average 90 stars, based on 1 article reviews
prometa software version 2 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Software:Article Title: CTLA-4 rs231775 and risk of acute renal graft rejection: an updated meta-analysis with trial sequential analysis Article Snippet: .. All analyses were performed using Article Title: Impact of ATM rs1801516 on late skin reactions of radiotherapy for breast cancer: Evidences from a cohort study and a trial sequential meta-analysis Article Snippet: .. All analyses were performed using Article Title: Diagnostic accuracy of NUDT15 gene variants for thiopurine-induced leukopenia: a systematic review and meta-analysis. Article Snippet: We herein conducted a systematic review and meta-analysis of published studies to estimate diagnostic accuracy of NUDT15 gene polymorphisms for detection of thiopurine-induced leukopenia.. Eligible studies were identified through a comprehensive search on PubMed, Web of Knowledge, Cochrane and OpenGrey datasets up to April 2018.. The methodological quality of eligible studies was assessed using the QUADAS-2 criteria. Article Title: Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis. Article Snippet: Accepted Manuscript Title: Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: a systematic review and meta-analysis Authors: Sarah Cargnin, Gloria Ravegnini, Simona Soverini, Sabrina Angelini, Salvatore Terrazzino PII: S1043-6618(17)31523-2 DOI: https://doi.org/10.1016/j.phrs.2018.02.005 Reference: YPHRS 3817 To appear in: Pharmacological Research Received date: 28-11-2017 Revised date: 23-1-2018 Accepted date: 6-2-2018 Please cite this article as: Cargnin Sarah, Ravegnini Gloria, Soverini Simona, Angelini Sabrina, Terrazzino Salvatore.Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: a systematic review and metaanalysis.Pharmacological Research https://doi.org/10.1016/j.phrs.2018.02.005 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. |